Drug intelligence / Profile preview

haritaki churna

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

Haritaki churna is a traditional Ayurvedic herbal formulation consisting of the powdered fruit of *Terminalia chebula*. It is traditionally used for gastrointestinal health and as a rejuvenative (Rasayana) tonic. Modern pharmacological studies indicate that its aqueous extract (HCAE) possesses significant anti-cancer activity, particularly against colorectal and esophageal cancer cells. Its mechanism involves the action of bioactive polyphenols like ellagic acid and chebulinic acid, which induce S-phase cell cycle arrest and mitochondrial apoptosis. Network pharmacology has identified several protein targets, including c-Src kinase, EGFR, and Akt1, which are downregulated by the formulation. It is also used as an adjuvant therapy in conditions like trigger finger due to its anti-inflammatory and strengthening properties.

Other names
Terminalia chebula powderHCHCAE
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)BCL-2 (BCL-2 family)CASP3 (Caspase-3)EGFR (Epidermal growth factor receptor)ESR1 (ERα)HSP90AA1 (Heat shock protein HSP90-alpha)SRC (Proto-oncogene tyrosine-protein kinase Src)PARP1 (Poly (adp-ribose) polymerase 1)

Beyond the preview

Go deeper on haritaki churna.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on haritaki churna.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call